Effects of Ca2+-sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts

Journal of Muscle Research and Cell Motility

Volumn 25, Issue 3, 2004, Pages 219-224

  Papp, Z ^a   Van Der Velden, J ^b   Borbely A ^a   Edes I ^a   Stienen, G J M ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; CALCIUM ION; CALCIUM SENSITIZER; N [4 (1,4,5,6 TETRAHYDRO 4 METHYL 6 OXO 3 PYRIDAZINYL)PHENYL]ACETAMIDE; PHOSPHATE; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; CALCIUM; N (4 (4 METHYL 6 OXO 1,4,5,6 TETRAHYDROPYRIDAZIN 3 YL)PHENYL)ACETAMIDE; N-(4-(4-METHYL-6-OXO-1,4,5,6-TETRAHYDROPYRIDAZIN-3-YL)PHENYL)ACETAMIDE; PYRIDAZINE DERIVATIVE; QUINOLINE DERIVATIVE; THIADIAZINE DERIVATIVE;

ACTIN MYOSIN INTERACTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MEMBRANE STEADY POTENTIAL; MUSCLE FIBRIL; MUSCLE ISOMETRIC CONTRACTION; PRIORITY JOURNAL; SENSITIZATION; THIN FILAMENT; ADULT; AGED; CELL MEMBRANE PERMEABILITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DONOR; DRUG EFFECT; FEMALE; HEART MUSCLE CELL; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED;

ACETAMIDES; ADULT; AGED; CALCIUM; CELL MEMBRANE PERMEABILITY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; PYRIDAZINES; QUINOLINES; THIADIAZINES; TISSUE DONORS;

EID: 16644369017     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1023/B:JURE.0000038365.74532.75     Document Type: Article

References (32)

1. Bodor GS, Oakeley AE, Allen PD, Crimmins DL, Ladenson JH and Anderson PA (1997) Troponin I phosphorylation in the normal and failing adult human heart. Circulation 96: 1495-1500.
2. 2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci 85: 3265-3269.
3. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 77: 107-113.
4. Fabiato A (1981) Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol 78: 457-497.
5. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L and Steering Committee and Investigators of the Levosimendan Infusion vs. Dobutamine (LIDO) Study (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 360: 196-202.
6. 2+ sensitizers impair cardiac relaxation in failing human myocardium. J Pharmacol Exp Ther 280: 247-254.
7. 2+ sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-methyl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips. Arzneimittelforschung 46: 586-593.
8. Holubarsch C, Ludemann J, Wiessner S, Ruf T, Schulte-Baukloh H, Schmidt-Schweda S, Pieske B, Posival H and Just H (1998) Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation. Cardiovasc Res 37: 46-57.
9. Kentish JC (1991) Combined inhibitory actions of acidosis and phosphate on maximum force production in rat skinned cardiac muscle. Pflügers Arch 419: 310-318.
10. Kögler H, Plathow C, Al-Hillawi E, Trayer IP and Ruegg JC (1998) Replacement of troponin-I in slow-twitch skeletal muscle alters the effects of the calcium sensitizer EMD 53998. Pflügers Arch 436: 198-406.
11. Kraft T and Brenner B (1997) Force enhancement without changes in cross-bridge turnover kinetics: the effect of EMD 57033. Biophys J 72: 272-281.
12. Lee JA and Allen DG (1997) Calcium sensitizers: mechanisms of action and potential usefulness as inotropes. Cardiovasc Res 36: 10-20.
13. Levine RJ, Kensler RW, Yang Z, Stull JT and Sweeney HL (1996) Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J 71: 898-907.
14. Morano I, Hädicke K, Haase H, Bohm M, Erdmann E and Schaub MC (1997) Changes in essential myosin light chain isoform expression provide a molecular basis for isometric tension regulation in the failing human heart. J Mol Cell Cardiol 29: 1177-1187.
15. Palmer S, Di Bello S and Herzig JW (1995) The effects of EMD 57033 on rigor tension in porcine skinned cardiac trabecula. Eur J Pharmacol 294: 83-90.
16. 2+ sensitivity of mammalian skinned cardiac and skeletal muscle fibres. J Physiol 480: 45-60.
17. Papp Z, Szabó Á, Barends JP and Stienen GJM (2002) The mechanism of the force enhancement by MgADP under simulated ischemic conditions in rat cardiac myocytes. J Physiol 543: 177-189.
18. Pérez NG, Hashimoto K, McCune S, Altschuld RA and Marban E (1999) Origin of contractile dysfunction in heart failure, calcium cycling versus myofilaments. Circulation 99: 1077-1083.
19. Regnier M, Morris C and Homsher E (1995) Regulation of the cross-bridge transition from a weakly to strongly bound state in skinned rabbit muscle fibers. Am J Physiol 269: C1532-C1539.
20. Solaro RJ, Gambassi G, Warshaw DM, Keller MR, Spurgeon HA, Beier N and Lakatta EG (1993) Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res 73: 981-990.
21. Soergel DG, Georgakopoulos D, Stull LB, Kass DA and Murphy AM (2004) Augmented systolic response to the calcium sensitizer EMD 57033 in a transgenic model with troponin I truncation. Am J Physiol Heart Circ Physiol 286: H1785-H1792.
22. Strauss JD, Zeugner C and Ruegg JC (1992) The positive inotropic calcium sensitizer EMD 53998 antagonizes phosphate action on cross-bridges in cardiac skinned fibers. Eur J Pharmacol 227: 437-441.
23. Szilagyi S, Pollesello P, Levijoki J, Kaheinen P, Haikala H, Edes I and Papp Z (2004) The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. Eur J Pharmacol 486: 67-74.
24. Takahashi R, Talukder MA and Endoh M (2000a) Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium. J Cardiovasc Pharmacol 36: 118-125.
25. Takahashi R, Talukder MAH and Endoh M (2000b) Inotropic effects of OR-1896, an active metabolite of levosimendan on canine ventricular myocardium. Eur J Pharmacol 400: 103-112.
26. 2+ transients under acidotic condition in aequorin-loaded canine ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 366:440-448.
27. van der Velden J, Klein LJ, van der Bijl M, Huybregts MA, Stooker W, Witkop J, Eijsman L, Visser CA, Visser FC and Stienen GJM (1999) Isometric tension development and its calcium sensitivity in skinned myocyte-sized preparations from different regions of the human heart. Cardiovasc Res 42: 706-719.
28. van der Velden J, Klein LJ, Zaremba R, Boontje NM, Huybregts MA, Stooker W, Eijsman L, de Jong JW, Visser CA, Visser FC and Stienen GJM (2001) Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts. Circulation 104: 1140-1146.
29. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiorasc Res 57: 37-47.
30. 2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc Res 57: 505-514.
31. Vannier C, Lakomkine V and Vassort G (1997) Tension response of the cardiotonic agent (+)-EMD 57033 at the single cell level. Am J Physiol 272: C1586-CI593.
32. Wolff MR, Buck SH, Stoker SW, Greaser ML and Mentzer RM (1996) Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies. J Clin Invest 98: 167-176.